Assessment of proteins of the immune system

Clinical Immunology: Principles and Practice: Fourth Edition

Volumn , Issue , 2013, Pages 1145-1159

  Abraham, Roshini Sarah ^a   Barnidge, David R ^a   Lanza, Ian R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875702284     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7234-3691-1.00106-9     Document Type: Chapter

References (50)

1. Kipps T.J. Immunoglobulin genes. Manual of Molecular and Clinical Laboratory Immunology 2006, 56-68. ASM Press, Washington, DC. 7th ed. B. Detrick, R.G. Hamilton, J.D. Folds (Eds.).
2. Homburger H.A., Singh R.J. Assessment of proteins of the immune system. Clinical immunology: principles and practice 2008, 1419-1434. Mosby Elsevier, Philadelphia. 3rd ed. R.R. Rich, T.A. Fleisher, W.A. Shearer (Eds.).
3. Whicher J.T., Price C.P., Spencer K. Immunonephelometric and immunoturbidimetric assays for proteins. Crit Rev Clin Lab Sci 1983, 18:213-260.
4. Bradwell A.R., Harding S.J., Fourrier N.J., et al. Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa/lambda ratios. Clin Chem 2009, 55:1646-1655.
5. Keren D. Protein electrophoresis in clinical diagnosis 2003, Arnold, London.
6. Keren D., Humphrey R. Clinical indications and applications of serum and urine protein electrophoresis. Manual of molecular and clinical laboratory immunology 2006, 75-87. ASM Press, Washington, DC. 7th ed. B. Detrick, R. Hamilton, J. Folds (Eds.).
7. Katzmann J.A., Kyle R.A. Immunochemical characterization of immunoglobulins in serum, urine and cerebrospinal fluid. Manual of molecular and clinical laboratory immunology 2006, 88-100. ASM Press, Washington, DC. 7th ed. B. Detrick, R.G. Hamilton, J.D. Folds (Eds.).
8. Collins A., Colvin R., Nousari C. Immunofluorescence methods in the diagnosis of renal and skin diseases. Manual of molecular and clinical laboratory immunology 2006, 414-423. ASM Press, Washington, DC. 7th ed. B. Detrick, R. Hamilton, J. Folds (Eds.).
9. Tampoia M., Zucano A., Antico A., et al. Diagnostic accuracy of different immunological methods for the detection of antineuronal antibodies in paraneoplastic neurological syndromes. Immunol Invest 2010, 39:186-195.
10. Lequin R.M. Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA). Clin Chem 2005, 51:2415-2418.
11. Rissin D.M., Kan C.W., Campbell T.G., et al. Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat Biotechnol 2010, 28:595-599.
12. Earley M.C., Vogt R.F., Shapiro H.M., et al. Report from a workshop on multianalyte microsphere assays. Cytometry 2002, 50:239-242.
13. Hsu H.Y., Joos T.O., Koga H. Multiplex microsphere-based flow cytometric platforms for protein analysis and their application in clinical proteomics-from assays to results. Electrophoresis 2009, 30:4008-4019.
14. Kettman J.R., Davies T., Chandler D., et al. Classification and properties of 64 multiplexed microsphere sets. Cytometry 1998, 33:234-243.
15. Elshal M.F., McCoy J.P. Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods 2006, 38:317-323.
16. Famulok M., Hartig J.S., Mayer G. Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy. Chem Rev 2007, 107:3715-3743.
17. Platt M., Rowe W., Wedge D.C., et al. Aptamer evolution for array-based diagnostics. Anal Biochem 2009, 390:203-205.
18. Colas P. The eleven-year switch of peptide aptamers. J Biol 2008, 7:2.
19. Tombelli S., Minunni M., Mascini M. Aptamers-based assays for diagnostics, environmental and food analysis. Biomol Eng 2007, 24:191-200.
20. Kersten B., Wanker E.E., Hoheisel J.D., et al. Multiplex approaches in protein microarray technology. Expert Rev Proteomics 2005, 2:499-510.
21. Hultschig C., Kreutzberger J., Seitz H., et al. Recent advances of protein microarrays. Curr Opin Chem Biol 2006, 10:4-10.
22. Hall D.A., Ptacek J., Snyder M. Protein microarray technology. Mech Ageing Dev 2007, 128:161-167.
23. Hartmann M., Roeraade J., Stoll D., et al. Protein microarrays for diagnostic assays. Anal Bioanal Chem 2009, 393:1407-1416.
24. Wilson D.S., Nock S. Recent developments in protein microarray technology. Angew Chem Int Ed Engl 2003, 42:494-500.
25. Korf U., Wiemann S. Protein microarrays as a discovery tool for studying protein-protein interactions. Expert Rev Proteomics 2005, 2:13-26.
26. Goodrich T.T., Wark A.W., Corn R.M., et al. Surface plasmon resonance imaging measurements of protein interactions with biopolymer microarrays. Methods Mol Biol 2006, 328:113-130.
27. Maynard J.A., Lindquist N.C., Sutherland J.N., et al. Surface plasmon resonance for high-throughput ligand screening of membrane-bound proteins. Biotechnol J 2009, 4:1542-1558.
28. Kurien B.T., Scofield R.H. Protein blotting: a review. J Immunol Methods 2003, 274:1-15.
29. Kurien B.T., Scofield R.H. Protein blotting and detection: methods and protocols 2009, Humana Press.
30. Perez O.D., Nolan G.P. Phospho-proteomic immune analysis by flow cytometry: from mechanism to translational medicine at the single-cell level. Immunol Rev 2006, 210:208-228.
31. Yates J.R., Ruse C.I., Nakorchevsky A. Proteomics by mass spectrometry: approaches, advances, and applications. Annu Rev Biomed Eng 2009, 11:49-79.
32. Zhang Z., Pan H., Chen X. Mass spectrometry for structural characterization of therapeutic antibodies. Mass Spectrom Rev 2009, 28:147-176.
33. Elliott M.H., Smith D.S., Parker C.E., et al. Current trends in quantitative proteomics. J Mass Spectrom 2009, 44:1637-1660.
34. Ge F., Tao S., Bi L., et al. Proteomics: addressing the challenges of multiple myeloma. Acta Biochim Biophys Sin (Shanghai) 2010, 43:89-95.
35. Barnidge D.R., Jelinek D.F., Muddiman D.C., et al. Quantitative protein expression analysis of CLL B cells from mutated and unmutated IgV(H) subgroups using acid-cleavable isotope-coded affinity tag reagents. J Proteome Res 2005, 4:1310-1317.
36. Tomazella G.G., daSilva I., Thome C.H., et al. Analysis of detergent-insoluble and whole cell lysate fractions of resting neutrophils using high-resolution mass spectrometry. J Proteome Res 2010, 9:2030-2036.
37. Tjalsma H., Schaeps R.M., Swinkels D.W. Immunoproteomics: From biomarker discovery to diagnostic applications. Proteomics Clin Appl 2008, 2:167-180.
38. Dekker L.J., Zeneyedpour L., Brouwer E., et al. An antibody-based biomarker discovery method by mass spectrometry sequencing of complementarity determining regions. Anal Bioanal Chem 2010, 399:1081-1091.
39. Trost M., Bridon G., Desjardins M., et al. Subcellular phosphoproteomics. Mass Spectrom Rev 2010, 29:962-990.
40. Nedelkov D. Integration of SPR biosensors with mass spectrometry (SPR-MS). Methods Mol Biol 2010, 627:261-268.
41. Spratlin J.L., Serkova N.J., Eckhardt S.G. Clinical applications of metabolomics in oncology: a review. Clin Cancer Res 2009, 15:431-440.
42. Dunn W.B., Bailey N.J., Johnson H.E. Measuring the metabolome: current analytical technologies. Analyst 2005, 130:606-625.
43. Bictash M., Ebbels T.M., Chan Q., et al. Opening up the "Black Box": metabolic phenotyping and metabolome-wide association studies in epidemiology. J Clin Epidemiol 2010, 63:970-979.
44. Zhang S., Nagana Gowda G.A., Ye T., et al. Advances in NMR-based biofluid analysis and metabolite profiling. Analyst 2010, 135:1490-1498.
45. Robertson D.G. Metabonomics in toxicology: a review. Toxicol Sci 2005, 85:809-822.
46. Shlomi T., Cabili M.N., Ruppin E. Predicting metabolic biomarkers of human inborn errors of metabolism. Mol Syst Biol 2009, 5:263.
47. Gowda G.A., Zhang S., Gu H., et al. Metabolomics-based methods for early disease diagnostics. Expert Rev Mol Diagn 2008, 8:617-633.
48. Wishart D.S. Metabolomics: the principles and potential applications to transplantation. Am J Transplant 2005, 5:2814-2820.
49. Wishart D.S. Metabolomics in monitoring kidney transplants. Curr Opin Nephrol Hypertens 2006, 15:637-642.
50. Ornatsky O., Bandura D., Baranov V., et al. Highly multiparametric analysis by mass cytometry. J Immunol Methods 2010, 361:1-20.